Skip to content
Preprint · OA via OpenAlex

Cellular Senescence in Obesity and Associated Complications: a New Therapeutic Target

Akilavalli Narasimhan, Rafael R. Flores, Christina D. Camell, David Bernlohr, Paul D. Robbins, Laura J. Niedernhofer

Current Diabetes Reports · 2022 · ▲ 38 citations

Abstract

This review in Current Diabetes Reports 2022 examines the role of cellular senescence(definition) in obesity. It assesses its potential as a therapeutic target.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1007/s11892-022-01493-w
Canonical
link ↗
Fetched
2026-10-05 MST

Cite this

APA
Narasimhan, A., Flores, R.R., Camell, C.D., Bernlohr, D., Robbins, P.D., &amp; Niedernhofer, L.J. (2022). Cellular Senescence in Obesity and Associated Complications: a New Therapeutic Target. <em>Current Diabetes Reports</em>. https://doi.org/10.1007/s11892-022-01493-w
Vancouver
Narasimhan A, Flores RR, Camell CD, Bernlohr D, Robbins PD, Niedernhofer LJ. Cellular Senescence in Obesity and Associated Complications: a New Therapeutic Target. Current Diabetes Reports. 2022. doi:10.1007/s11892-022-01493-w.
BibTeX
@unpublished{akilavalli2022Cellul, title = {Cellular Senescence in Obesity and Associated Complications: a New Therapeutic Target}, author = {Akilavalli Narasimhan and Rafael R. Flores and Christina D. Camell and David Bernlohr and Paul D. Robbins and Laura J. Niedernhofer}, journal = {Current Diabetes Reports}, year = {2022}, doi = {10.1007/s11892-022-01493-w}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings